These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24122884)

  • 1. Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: which measure of variability should be used?
    Salem F; Ogungbenro K; Vajjah P; Johnson TN; Aarons L; Rostami-Hodjegan A
    J Clin Pharmacol; 2014 Mar; 54(3):311-7. PubMed ID: 24122884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.
    Ginsberg G; Hattis D; Russ A; Sonawane B
    J Toxicol Environ Health A; 2004 Feb; 67(4):297-329. PubMed ID: 14713563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies.
    Wang Y; Jadhav PR; Lala M; Gobburu JV
    J Clin Pharmacol; 2012 Oct; 52(10):1601-6. PubMed ID: 22162537
    [No Abstract]   [Full Text] [Related]  

  • 5. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
    Johnson TN; Rostami-Hodjegan A
    Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
    Nong A; McCarver DG; Hines RN; Krishnan K
    Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.
    Navid A; Ng DM; Wong SE; Lightstone FC
    CPT Pharmacometrics Syst Pharmacol; 2016 Feb; 5(2):74-81. PubMed ID: 26933518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic (PBPK) modeling in children.
    Barrett JS; Della Casa Alberighi O; Läer S; Meibohm B
    Clin Pharmacol Ther; 2012 Jul; 92(1):40-9. PubMed ID: 22669290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age.
    Allen BC; Hack CE; Clewell HJ
    Risk Anal; 2007 Aug; 27(4):947-59. PubMed ID: 17958503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.
    Edginton AN; Shah B; Sevestre M; Momper JD
    Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam.
    Maharaj AR; Barrett JS; Edginton AN
    AAPS J; 2013 Apr; 15(2):455-64. PubMed ID: 23344790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of physiologically based pharmacokinetic models coupled with pharmacodynamic models to assess the clinical relevance of current bioequivalence criteria for generic drug products containing Ibuprofen.
    Cristofoletti R; Dressman JB
    J Pharm Sci; 2014 Oct; 103(10):3263-75. PubMed ID: 25043938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis.
    Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S
    Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.
    Johnson TN; Rostami-Hodjegan A; Tucker GT
    Clin Pharmacokinet; 2006; 45(9):931-56. PubMed ID: 16928154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
    Fay MP; Halloran ME; Follmann DA
    Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.